Trials / Completed
CompletedNCT02197598
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
Exploratory, Interventional, Open-label, Fixed-dose Study With Selincro® As-needed Use, in Alcohol Dependent Patients With Liver Impairment
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore the treatment effects of Selincro in alcohol dependent patients with liver impairment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nalmefene |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-12-01
- First posted
- 2014-07-22
- Last updated
- 2016-12-14
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02197598. Inclusion in this directory is not an endorsement.